Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Lenvatinib in Combination with Pembrolizumab Versus Treatment of Physician’s Choice in participants with Advanced Endometrial Cancer.
Phase: 3Phase III in Spain, 2Phase II, 1Phase I